Loading clinical trials...
Loading clinical trials...
Rationale: Desmoid-type fibromatosis (DTF) is a rare, histologically benign, soft tissue tumour. Although incapable of metastasizing, the clinical course is unpredictable and can be aggressive because...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Erasmus Medical Center
Collaborators
NCT07170644 · Desmoid Tumor, Aggressive Fibromatosis
NCT07461246 · Familial Adenomatous Polyposis (FAP), Attenuated Familial Adenomatous Polyposis (AFAP), and more
NCT04871282 · Desmoid, Desmoid Tumor
NCT03190174 · Ewing Sarcoma, PEComa, and more
NCT02076906 · Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, and more
3. Antoni van Leeuwenhoek Ziekenhuis (AVL) / The Netherlands Cancer Instituut , Amsterdam, The Netherlands
Amsterdam
Radboud University Medical Center (MC), Nijmegen, The Netherlands
Nijmegen
Erasmus MC Cancer Institute
Rotterdam
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions